Please provide your email address to receive an email when new articles are posted on . In an update to its guidance on primary osteoporosis, ACP recommended bisphosphonates as a first line of defense ...

The American College of Physicians updated its 2017 guideline on pharmacologic treatment of osteoporosis or low bone mass to prevent fractures in adults. In a shift from previous recommendations, the ...

Philadelphia, PA - A review of jaw osteonecrosis as a recently described adverse effect of bisphosphonate therapy in the May 16, 2006 issue of the Annals of Internal Medicine concludes that most cases ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window About a year was ...

The American College of Physicians’ new osteoporosis treatment guidelines support individualized medication plans, suggest an ideal length of therapy and take the clinical needs of seniors into ...

Q: What are your thoughts on prescribing oral bisphosphonates for osteoporosis? I am wary of prescribing them in younger patients because these agents have long half-lives and seem to be associated ...

Please provide your email address to receive an email when new articles are posted on . Despite potential side effects, bisphosphonate therapy may benefit postmenopausal women with osteoporosis by ...

1. American College of Physicians recommends bisphosphonates for initial treatment for osteoporosis in males and postmenopausal females diagnosed with primary ...

Patients with glucocorticoid-induced osteoporosis on romosozumab show greater gains in lumbar spine bone mineral density than those on denosumab and comparable gains with those on teriparatide.

People who take bisphosphonates for osteoporosis may be at risk for serious atrial fibrillation (AF), or irregular heartbeats, according to a new study. The research, presented at CHEST 2008, the 74th ...